Our Mission
PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Myeloma Chemotherapy- Chemosensitivity Testing-
Myeloma Chemotherapy- Chemosensitivity Testing-
“Chemosensitivity Testing-The screening method suggests which commonly prescribed multiple myeloma drug or combination of drugs should be considered first for a particular patient”
Testing one’s multiple myeloma in an effort to determine which MM chemotherapy drug or drugs will work best for you aka “chemosensitivity testing” is a great concept.
So great, in fact, that the idea has been around for years. The first article linked and excerpted below is from 2004, the year that PeopleBeatingCancer was founded. At the time, I thought chemosensitivity testing would revolutionize the diagnosis and treatment of multiple myeloma.
The second article linked below was published more than 10 years later. Chemosensitivity testing is still being trialed/tested. Someday we’ll figure it out.
Have you been diagnosed with multiple myeloma? What stage? What symptoms? Bone pain? Anemia?
I am a long-term myeloma survivor and myeloma cancer coach. Aggressive conventional therapies did little for me. I live an evidence-based, non-toxic, anti-MM lifestyle through nutrition, supplementation, bone health and more.
Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Recommended Reading:
- A Bone Cancer? A Blood Cancer? No, it is Plasma Cell Multiple Myeloma-
- Key Questions for Multiple Myeloma Patients
- Role of Autologous Stem Cell Transplant for You-Multiple Myeloma
Chemotherapy Sensitivity and Resistance Assays: A Systematic Review
“This systematic review evaluates evidence comparing therapy guided by chemotherapy sensitivity and resistance assays with empiric chemotherapy, emphasizing survival outcomes…
Conclusion- While higher response rates for assay-guided therapy have been observed, differences may be attributable to bias or confounding. Little evidence on survival is available. These results do not establish the relative effectiveness of assay-guided treatment and empiric treatment. Randomized trials are needed.”
Personalized Drug Screen Aids Treatment Selection for Patients with Multiple Myeloma
“A personalized testing method may quickly and more accurately predict the effectiveness of a treatment for multiple myeloma in individual patients…
The screening method suggests which commonly prescribed multiple myeloma drug or combination of drugs should be considered first for a particular patient. The test also suggests optimum dosage…
Even before the patient completes all of the MRIs, CT scans, and other imaging procedures following diagnosis, we can have a recommendation for which drug and dosage to prescribe…